Clinical Trial Update: Fasudil Eye Drop in Retinopathy Of Prematurity(ROP) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for Fasudil eye drops targeting retinopathy of prematurity (ROP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Fasudil eye drops (fasudil)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Retinopathy of Prematurity | Phase 2, Phase 3 | Status: UNKNOWN